NCT01747746View on ClinicalTrials.gov

Anticoagulation With Rivaroxaban in Cardioversion -The ARC Study

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Atrial FibrillationStrokeThrombo-embolismBleeding
Interventions
DRUG

Rivaroxaban

Rivaroxaban versus Historical controlled Anticoagulation with Warfarin and Enoxaparin

DRUG

Warfarin and Enoxaparin

Historical Control

Trial Locations (1)

60612

Cook County Hospital, Chicago

All Listed Sponsors
collaborator

Cook County Hospital

OTHER

lead

Cook County Health

OTHER_GOV

NCT01747746 - Anticoagulation With Rivaroxaban in Cardioversion -The ARC Study | Biotech Hunter | Biotech Hunter